{
    "id": 3638,
    "fullName": "FGFR2 F276C",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "FGFR2 F276C lies within the Ig-like C2-type domain 3 of the Fgfr2 protein (UniPort.org). F276C results in increased Fgfr2 expression, altered cellular localization, and ligand-independent Erk phosphorylation in culture (JCO Precis Oncol 2017:1, 1-13).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 12754,
                    "pubMedId": null,
                    "title": "Molecular Modeling and Functional Analysis of Exome Sequencing\u2013Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma",
                    "url": "http://ascopubs.org/doi/full/10.1200/PO.17.00018"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2263,
        "geneSymbol": "FGFR2",
        "terms": [
            "FGFR2",
            "BBDS",
            "BEK",
            "BFR-1",
            "CD332",
            "CEK3",
            "CFD1",
            "ECT1",
            "JWS",
            "K-SAM",
            "KGFR",
            "TK14",
            "TK25"
        ]
    },
    "variant": "F276C",
    "createDate": "03/10/2015",
    "updateDate": "12/02/2018",
    "referenceTranscriptCoordinates": {
        "id": 89997,
        "transcript": "NM_000141",
        "gDna": "chr10:g.121520091A>C",
        "cDna": "c.827T>G",
        "protein": "p.F276C",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15393,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase II trial, BGJ398 treatment resulted in partial response after 2 month of therapy and maintained the response for 4 months in a patient with advanced intrahepatic cholangiocarcinoma harboring a FGFR2 F276C mutation, which is consistent with inhibition of Erk signaling in cholangiocarcinoma cells expressing FGFR2 F274C in culture (JCO Precis Oncol 2017:1, 1-13; NCT02150967).",
            "molecularProfile": {
                "id": 3439,
                "profileName": "FGFR2 F276C"
            },
            "therapy": {
                "id": 674,
                "therapyName": "BGJ398",
                "synonyms": null
            },
            "indication": {
                "id": 4928,
                "name": "intrahepatic cholangiocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 12754,
                    "pubMedId": null,
                    "title": "Molecular Modeling and Functional Analysis of Exome Sequencing\u2013Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma",
                    "url": "http://ascopubs.org/doi/full/10.1200/PO.17.00018"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 3439,
            "profileName": "FGFR2 F276C",
            "profileTreatmentApproaches": [
                {
                    "id": 19170,
                    "name": "FGFR2 Inhibitor",
                    "profileName": "FGFR2 F276C"
                },
                {
                    "id": 19169,
                    "name": "FGFR Inhibitor (Pan)",
                    "profileName": "FGFR2 F276C"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 89996,
            "transcript": "NM_001320658",
            "gDna": "chr10:g.121520091A>C",
            "cDna": "c.827T>G",
            "protein": "p.F276C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 89998,
            "transcript": "NM_022970",
            "gDna": "chr10:g.121520091A>C",
            "cDna": "c.827T>G",
            "protein": "p.F276C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 89999,
            "transcript": "NM_001144913",
            "gDna": "chr10:g.121520091A>C",
            "cDna": "c.827T>G",
            "protein": "p.F276C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 89997,
            "transcript": "NM_000141",
            "gDna": "chr10:g.121520091A>C",
            "cDna": "c.827T>G",
            "protein": "p.F276C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 89995,
            "transcript": "NM_001144917",
            "gDna": "chr10:g.121520091A>C",
            "cDna": "c.827T>G",
            "protein": "p.F276C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}